March 28, 2016

NRG Oncology funding depends on corresponding authors' compliance with NIH Manuscript Submission System (NIHMS) requirements. If authors do not comply, we will not receive our grant funds. If you are the corresponding author on a manuscript to be published under NRG auspices, please click here and note your responsibilities under the NIH Public Access policy.

If you have problems with the NIHMS system, you can call one of the editorial offices for help:
Buffalo: Kim Blaser, 716-845-1786
Philly West: Suzanne Baldwin, 215-574-3180
Pittsburgh: Christine Rudock, 412-339-5281

CLOSURE NOTICES
GYNECOLOGIC
GOG-0127W:Termination effective January 25, 2016; Amendment 12, Version Date: December 15, 2014

GOG-0218:Termination effective January 23, 2016

AMENDMENTS AND UPDATES
HEAD & NECK
RTOG 1016: Amendment 8, Version Date: February 23, 2016

RTOG 0912
: Amendment 10, Version Date: March 8, 2016

RTOG 1112 (Attn: Canadian sites) Health Canada determined a NOL will not be issued for amendment 4. This amendment meets the requirements of a notification and a letter from Health Canada will not be issued. Please proceed with REB/IRB submission.

OTHER PROTOCOL NOTICES
RTOG 9804: An important statistical analysis is being planned. Please review the OPS tool and patient calendars and submit all outstanding data as soon as possible. Additionally, please be sure to submit all data due in the next couple months and all future data as soon as it’s available.

Vision Tree Webinar
The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, RTOG 0920, RTOG 0928, NRG-HN001 and NRG-HN002. Space is limited so register now and reserve your seat. The next webinar training is scheduled for April 13, 2016.

DRUG SAFETY UPDATES
Safety updates have been issued for NSABP legacy studies. For details, please see the NSABP Members’ Area or the E-mail Distributions page and the CTSU website.

Safety updates have been issued for the following NRG Oncology studies:
Cediranib: NRG-GY004, NRG-GY005
For NRG-GY004 and NRG-GY005 safety reports, please see the CTSU website.

HOLIDAY CLOSURES
The NHMRC Clinical Trials Centre will be closed on Monday, March 28, 2016 due to the Easter Monday public holiday. See memo for details.

Please note the following upcoming meeting and abstract submission deadline dates.

Upcoming Meetings
American Association for Cancer Research (AACR), Apr 16-20, 2016, New Orleans, LA
American Association of Neurological Surgeons (AANS), Apr 30-May 4, 2016, Chicago, IL
American Radium Society (ARS), Apr 16-19, 2016, Philadelphia, PA
American Society of Breast Surgeons (ASBS), April 13-17, 2016, Dallas, TX
American Society of Colon and Rectal Surgeons (ASCRS), Apr 30-May 4, 2016, Los Angeles, CA
European Society for Radiotherapy and Oncology (ESTRO), Apr 29-May 3, 2016, Turin, Italy

Upcoming abstract submission deadlines
Cochrane Colloquium; Oct 23-27, 2016; Seoul, South Korea; due to publications committee Mar 30, 2016; meeting abstract submission deadline Apr 13, 2016
International Society for Quality of Life Research (ISOQOL); Oct 19-22, 2016, Copenhagen, Denmark; due to publications committee Apr 1, 2016; meeting abstract submission deadline Apr 18, 2016
Radiological Society of North America (RSNA); Nov 27-Dec 2, 2016;Chicago, IL due to publications committee Mar 30, 2016; meeting abstract submission deadline Apr 13, 2016
Western Association of Gynecologic Oncologists (WAGO); Jun 8-11, 2016; Sedona, AZ; meeting abstract submission deadline Mar 28, 2016

View this email in your browser
You are receiving this email because of your relationship with NRG Oncology. Please reconfirm your interest in receiving emails from us. If you do not wish to receive any more emails, you can unsubscribe here.

Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103


Unsubscribe